SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.
(深圳市海普瑞藥業集團股份有限公司)
(A joint stock company incorporated in the People's Republic of China with limited liability)
(Stock Code: 9989)
PROXY FORM
FOR THE 2020 ANNUAL GENERAL MEETING
TO BE HELD ON WEDNESDAY, MAY 26, 2021 (OR ANY ADJOURNMENT THEREOF)
I/We (Note 1) | , | |||
of (Note 2) | being | |||
the registered holder(s) of (Note 3) | H shares of RMB1.00 each in the |
share capital of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company"), hereby appoint the Chairman of the meeting or (full name)
of (address)
to act as my/our proxy to attend and vote for me/us and on my/our behalf at the 2020 annual general meeting (the "AGM") of the Company to be held at 2:30 p.m. on Wednesday, May 26, 2021 at Ballroom, 2/F, L'Hermitage Hotel, 3031 Nanhai Boulevard, Nanshan District, Shenzhen, the People's Republic of China (the "PRC") and at any adjournment thereof for the purposes of considering and, if thought fit, passing the resolutions set out in the circular and notice (the "Notice") of the Company dated April 23, 2021 regarding the AGM and to exercise all rights conferred on proxies under laws, regulations and the articles of association of the Company in respect of the resolutions set out in the Notice of the AGM as hereunder, or if no such indication is given, as my/our proxy thinks fit.
No. | ORDINARY RESOLUTIONS | FOR(Note 6) | AGAINST(Note 6) | ABSTAIN(Note 6) | |||
(Resolutions adopting non-cumulative voting) | |||||||
1.00 | The resolution regarding the 2020 Work Report of the Board | ||||||
of Directors of the Company. | |||||||
2.00 | The resolution regarding the 2020 Work Report of the Board | ||||||
of Supervisors of the Company. | |||||||
3.00 | The resolution regarding the 2020 Annual Report and its | ||||||
Summary, H Shares Results Announcement, H Shares 2020 | |||||||
Annual Report, 2020 Corporate Governance Report and 2020 | |||||||
Environmental, Social and Governance Report of the Company. | |||||||
4.00 | The resolution regarding the 2020 Final Financial Report of | ||||||
the Company. | |||||||
5.00 | The resolution regarding the 2020 Profit Distribution Proposal | ||||||
of the Company. | |||||||
6.00 | The resolution regarding the re-appointment of auditors of | ||||||
the Company. | |||||||
SPECIAL RESOLUTIONS | FOR | (Note 6) | AGAINST | (Note 6) | ABSTAIN | (Note 6) | |
(Resolutions adopting non-cumulative voting) | |||||||
7.00 | The resolution regarding the 2021-2023 Shareholder Return | ||||||
Three-Year Plan of the Company. | |||||||
8.00 | The resolution regarding the application for credit line and | ||||||
providing guarantee to certain banks for 2021 of the Company. | |||||||
9.00 | The resolution regarding the purchase of wealth management | ||||||
products and cash flow management using part of the | |||||||
unemployed H Shares IPO Proceeds of the Company. | |||||||
ORDINARY RESOLUTION | FOR | (Note 6) | AGAINST | (Note 6) | ABSTAIN | (Note 6) | |
(Resolution adopting non-cumulative voting) | |||||||
10.00 | The resolution regarding the appointment of executive | ||||||
director of the Company. |
Date: | Signature(s) (Note 7): |
Notes:
- Please insert full name(s) in BLOCK CAPITALS.
- Please insert full address(es) in BLOCK CAPITALS.
- Please insert the number of H shares of the Company registered in your name(s) to which this proxy form relates. If no number of shares is inserted, this proxy form will be deemed to relate to all H shares of the Company registered in your name(s).
- If you are a shareholder of the H shares of the Company (the "H Shares Shareholder") who is entitled to attend and vote at the meeting, you are entitled to appoint one or more proxies to attend instead of you and to vote on your behalf. A proxy need not be a H Shares Shareholder, but must attend the meeting in person in order to represent you.
- If any proxy other than the Chairman of the meeting is preferred, please strike out the words "the Chairman of the meeting" and insert the full name and address of the proxy (or proxies) desired in the space provided. If no name is inserted, the Chairman of the meeting will act as your proxy. ANY ALTERATION MADE TO THIS PROXY FORM MUST BE INITIALLED BY THE PERSON(S) WHO SIGNS IT.
- IMPORTANT: IF YOU WISH TO VOTE FOR A RESOLUTION, TICK () IN THE RELEVANT BOX BELOW THE BOX MARKED "FOR". IF YOU WISH TO VOTE AGAINST A RESOLUTION, TICK () IN THE RELEVANT BOX BELOW THE BOX MARKED "AGAINST". IF YOU WISH TO ABSTAIN, TICK () IN THE RELEVANT BOX BELOW THE BOX MARKED "ABSTAIN". If you return this proxy form without indicating as to how your proxy is to vote on any particular matter, the person appointed as your proxy will exercise his/her discretion as to whether he/she votes and, if so, how and, unless instructed otherwise, he/she may also vote or abstain from voting as he/she thinks fit on any other business (including amendments to resolutions) which may be proposed at the meeting. The shares abstained will be counted in the calculation of the required majority.
- This proxy form must be signed and dated by the H Shares Shareholder or his/her attorney duly authorized in writing. If the H Shares Shareholder is a company, it should execute this proxy form under its common seal or by its directors or (a) person(s) duly authorized to sign on its behalf. In case of joint holders, only the person whose name stands first on the register of members may attend and vote at the AGM, either in person or by proxy.s
- To be valid, this proxy form, together with the power of attorney or other authority, if any, under which it is signed, or a notary certified copy of such power of attorney or authority, must be completed and deposited at the H Shares registrar of the Company, Tricor Investor Services Limited, at Level 54, Hopewell Centre, 183 Queen's Road East, Hong Kong not less than 24 hours before the meeting or any adjournment thereof.
- Completion and return of this proxy form will not preclude you from attending and voting at the meeting in person if you so wish.
- H Shares Shareholders or their proxies attending the meeting shall produce their identity documents.
Attachments
- Original document
- Permalink
Disclaimer
Shenzhen Hepalink Pharmaceutical Group Co. Ltd. published this content on 22 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 April 2021 11:19:03 UTC.